Get the Stockscreener App
17.45
0.85%
-0.15
After Hours:
17.40
-0.05
-0.29%
Mediwound Ltd stock is traded at $17.45, with a volume of 87,154.
It is down -0.85% in the last 24 hours and up +1.34% over the past month.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
See More
Previous Close:
$17.60
Open:
$17.23
24h Volume:
87,154
Relative Volume:
0.89
Market Cap:
$223.97M
Revenue:
$19.85M
Net Income/Loss:
$-12.75M
P/E Ratio:
-12.64
EPS:
-1.38
Net Cash Flow:
$-21.94M
1W Performance:
-0.40%
1M Performance:
+1.34%
6M Performance:
+7.12%
1Y Performance:
+4.18%
1-Day Range:
$16.82
$17.57
1-Week Range:
$16.82
$17.81
52-Week Range:
$14.14
$22.50
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
17.45 | 225.90M | 19.85M | -12.75M | -21.94M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| May-02-25 | Initiated | Alliance Global Partners | Buy |
| Feb-28-25 | Initiated | Craig Hallum | Buy |
| Jul-16-24 | Reiterated | Maxim Group | Buy |
| Dec-22-22 | Initiated | Maxim Group | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Sep-23-20 | Initiated | BTIG Research | Buy |
| Nov-28-16 | Initiated | Aegis Capital | Buy |
| Aug-17-16 | Initiated | Wells Fargo | Outperform |
| Apr-16-14 | Initiated | Oppenheimer | Outperform |
View All
Mediwound Ltd Stock (MDWD) Latest News
MediWound Files Annual Report on Form 20-F - GlobeNewswire
MediWound Q4 2025 Earnings Call Transcript - MarketBeat
MediWound Ltd. Q4 2025 Earnings Call Summary - Yahoo Finance
MediWound (NASDAQ:MDWD) Releases Quarterly Earnings Results - MarketBeat
MediWound (MDWD) Q4 2025 Earnings Call Transcript - AOL.com
MDWD: Expanded manufacturing, clinical progress, and strong guidance despite 2025 revenue decline - TradingView
MediWound (MDWD) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
MediWound: Q4 Earnings Snapshot - kens5.com
Mediwound earnings beat by $0.03, revenue fell short of estimates - Investing.com India
MDWD Maintains Revenue Forecasts Through 2028 - GuruFocus
MediWound (MDWD) Reports Lower-than-Expected Q4 Revenue - GuruFocus
MediWound: Overview of Fourth Quarter Financial Results - Bitget
MEDIWOUND ($MDWD) Releases Q4 2025 Earnings - Quiver Quantitative
MediWound Posts 2025 Loss but Strengthens Cash and Advances EscharEx, NexoBrid Capacity - TipRanks
MediWound (NASDAQ: MDWD) posts 2025 loss with cash rising above $53M - Stock Titan
Insights into MediWound Q4 Earnings - Benzinga
MediWound boosts burn drug output sixfold, guides to $24–26M 2026 sales - Stock Titan
MediWound Ltd. recently announced that it has once again confirmed its financial forecast targets for the coming years. - Bitget
What to Expect from MediWound's Earnings - Benzinga
Earnings Preview: MediWound to Report Financial Results Pre-market on March 05 - 富途牛牛
Mediwound Ltd expected to post a loss of 63 cents a shareEarnings Preview - TradingView
MediWound at TD Cowen Conference: Strategic Growth and Market Expansion - Investing.com India
MediWound Updates NexoBrid Growth, EscharEx Phase III Timeline and BARDA Talks at Oppenheimer Conference - MarketBeat
Clal Insurance Enterprises Holdings Ltd Acquires New Position in MediWound Ltd. $MDWD - MarketBeat
MediWound at Oppenheimer Conference: Strategic Growth and Innovation By Investing.com - Investing.com Australia
MediWound (MDWD) Expected to Announce Earnings on Thursday - MarketBeat
(MDWD) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
MediWound (NASDAQ:MDWD) Share Price Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Will MediWound Ltd. stock benefit from green energy trendsEarnings Summary Report & Safe Swing Trade Setups - mfd.ru
MediWound Shareholders Approve Expansion of 2024 Equity Incentive Pool - The Globe and Mail
MediWound to Report Fourth Quarter and Full Year 2025 Financial Results - Bitget
Will MediWound Ltd. stock outperform international peersJuly 2025 Spike Watch & Fast Entry and Exit Trade Plans - mfd.ru
MediWound Ltd. (NASDAQ:MDWD) Short Interest Up 20.9% in January - MarketBeat
MediWound to Present at Upcoming Investor Conferences - Bitget
MediWound Ltd. (NASDAQ:MDWD) Receives $33.50 Consensus PT from Analysts - Defense World
How (MDWD) Movements Inform Risk Allocation Models - Stock Traders Daily
Why MediWound Ltd. stock is favored by pension funds2025 EndofYear Setup & Smart Swing Trading Techniques - mfd.ru
Will MediWound Ltd. benefit from sector rotationMarket Risk Report & Technical Confirmation Alerts - mfd.ru
VIX Spike: Should I set a stop loss on MediWound LtdJuly 2025 Snapshot & AI Optimized Trading Strategy Guides - baoquankhu1.vn
What is MediWound Ltd.’s market position2025 Momentum Check & Risk Adjusted Buy/Sell Alerts - mfd.ru
HOLD Alapkezelo Zrt. discloses 8.1% MediWound (MDWD) ownership in amended filing - Stock Titan
Rally Mode: Will MediWound Ltd stock recover after earningsBull Run & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
MediWound Ltd. (NASDAQ:MDWD) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Yelin Lapidot Holdings Management Ltd. Adjusts Stake in MediWoun - GuruFocus
Can MediWound Ltd. stock beat market expectations this quarterEarnings Beat & Weekly Watchlist for Hot Stocks - mfd.ru
Can MediWound Ltd. stock deliver consistent earnings growthWeekly Loss Report & Reliable Price Action Trade Plans - mfd.ru
Can MediWound Ltd keep up with sector leadersPortfolio Profit Report & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
MediWound (NASDAQ:MDWD) Share Price Crosses Above 50-Day Moving AverageShould You Sell? - MarketBeat
Trading Systems Reacting to (MDWD) Volatility - Stock Traders Daily
Aug Spikes: Will MediWound Ltd outperform the market in YEAR2025 Risk Factors & Precise Buy Zone Identification - baoquankhu1.vn
MediWound’s EscharEx: A Late-Stage Asset Built for a Re-Normalized Wound Care Market (NASDAQ: MDWD) - TradingView
Mediwound Ltd Stock (MDWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):